| Financial Year |
March 31 2023 |
| Monetary Funds |
300,812,644.79 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
403,096,912.04 |
| Advances to Suppliers |
149,346,374.66 |
| Other Receivables |
123,628,737.54 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
643,980,727.26 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
53,231,215.37 |
| Total Current Assets |
1,677,666,111.66 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
45,868,266.93 |
| Investment Properties |
100,773,994.29 |
| Fixed Assetes |
1,231,463,308.29 |
| Under-construction Projects |
11,587,830.96 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
27,747,927.60 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
184,241,480.90 |
| R&D expenses |
-- |
| Goodwill |
112,200,000.00 |
| Long-Term Deferred and Prepaid Expenses |
1,557,182.79 |
| Deferred Income Tax Assets |
14,627,522.82 |
| Other Non-Current Assets |
1,546,000.00 |
| Sub-Total of Non-Current Assets |
1,809,085,640.32 |
| Total Assets |
3,486,751,751.98 |
| Short-Term Loans |
230,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
243,145,235.17 |
| Accounts Received In Advance |
5,954,407.10 |
| Employee Compensation Payable |
22,150,816.39 |
| Taxes Payable |
30,030,970.32 |
| Interest Payable |
4,511,601.11 |
| Dividend Payable |
-- |
| Other payables |
300,879,062.95 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
15,869,670.87 |
| Other Current Liabilities |
15,977,803.75 |
| Sub-Total of Current Liabilities |
984,392,193.77 |
| Long-term Loans |
80,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
901,678,706.25 |
| Special Payable |
-- |
| Estimatied Liabilities |
9,030,691.35 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,123,111,147.63 |
| Total Liabilities |
2,107,503,341.40 |
| Paid-In Capital(Or Share Stock) |
2,132,890,071.00 |
| Capital Surplus |
2,844,349,318.76 |
| Surplus Reserve |
40,077,376.33 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-3,952,707,020.04 |
| Minority Stockholder's Interest |
353,279,168.82 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,025,969,241.76 |
| Owner's Equity（Stockholder's Equity） |
1,379,248,410.58 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,486,751,751.98 |
